Lantheus Holdings, Inc. (LNTH)
86.15
+0.33
(+0.38%)
USD |
NASDAQ |
May 06, 16:00
89.00
+2.85
(+3.31%)
Pre-Market: 08:20
Lantheus Holdings Cash from Investing (Quarterly) : -11.51M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -1.239M |
| BioCryst Pharmaceuticals, Inc. | -- |
| Azenta, Inc. | -113.42M |
| Plus Therapeutics, Inc. | -1.077M |
| BioStem Technologies, Inc. | -0.4368M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 90.18M |
| Cash from Financing (Quarterly) | -100.79M |
| Free Cash Flow | 348.64M |
| Free Cash Flow Per Share (Quarterly) | 1.146 |
| Free Cash Flow to Equity (Quarterly) | 72.18M |
| Free Cash Flow to Firm (Quarterly) | 79.88M |
| Free Cash Flow Yield | 5.87% |